Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD
Alessandro Dinoto, Elia Sechi, Sérgio Ferrari, Alberto Gajofatto, Riccardo Orlandi, Paolo Solla, Alessandra Maccabeo, Giorgia Teresa Maniscalco, Vincenzo Andreone, Arianna Sartori, Paolo Manganotti, Sarah Rasia, Ruggero Capra, Chiara Mancinelli, Sara Mariotto
Topics & Concepts
MedicineMultiple sclerosisDiseaseCoronavirus disease 2019 (COVID-19)Vaccination2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicImmunologyDermatologyPathologyOutbreakInfectious disease (medical specialty)Peripheral Neuropathies and DisordersSystemic Lupus Erythematosus ResearchIgG4-Related and Inflammatory Diseases